Loading clinical trials...
Loading clinical trials...
PILOT CLINICAL TRIAL TO ASSESS THE IMPACT OF ORAL INTERVENTION WITH CETIL PYRIDINIUM CHLORIDE TO REDUCE THE VIRAL LOAD OF SARS-CoV-2
Conditions
Interventions
ORAL INTERVENTION WITH CETYLPYRIDINIUM CHLORIDE
PLACEBO
Locations
1
Spain
Seminario Health Center and Lozano Blesa University Clinical Hospital
Zaragoza, Spain
Start Date
February 3, 2021
Primary Completion Date
April 29, 2021
Completion Date
June 30, 2021
Last Updated
July 7, 2021
NCT06082518
NCT07221162
NCT06631287
NCT05141058
NCT06679140
NCT06417762
Lead Sponsor
Rosa Tarrago
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions